Drug targets in infections with Ebola and Marburg viruses

Area of Science:

• Virology
• Infectious Diseases
• Drug Discovery

Background:

• Filoviruses, including Ebola and Marburg viruses, pose significant global health threats.
• Current management for filovirus infections relies solely on supportive care, with no approved treatments or vaccines.
• The slow progress in developing effective antiviral therapies necessitates a review of the current landscape.

Purpose of the Study:

• To review existing treatments for filovirus infections.
• To identify potential therapeutic targets for novel antiviral drug development against filoviruses.
• To examine diverse drug targeting techniques applicable to filovirus research.

Main Methods:

• Comprehensive literature review of scientific publications and clinical trial data.
• Analysis of current therapeutic strategies and supportive care for filovirus disease.
• Evaluation of identified viral and host targets for antiviral intervention.
• Assessment of various drug delivery and targeting methodologies.

Main Results:

• Limited approved treatments exist for Ebola and Marburg virus infections.
• Several potential therapeutic targets within the filovirus lifecycle have been identified.
• Various drug targeting strategies, including small molecules and biologics, are under investigation.
• Supportive care remains the cornerstone of managing filovirus infections.

Conclusions:

• There is an urgent need for effective antiviral drugs and vaccines against filoviruses.
• Further research into potential therapeutic targets and drug delivery systems is crucial.
• Repurposing existing drugs and developing novel therapeutic agents are key strategies for future filovirus treatment.